NZ187617A - 1,4-dihydropyridine derivatives and pharmaceutical compositions - Google Patents

1,4-dihydropyridine derivatives and pharmaceutical compositions

Info

Publication number
NZ187617A
NZ187617A NZ187617A NZ18761778A NZ187617A NZ 187617 A NZ187617 A NZ 187617A NZ 187617 A NZ187617 A NZ 187617A NZ 18761778 A NZ18761778 A NZ 18761778A NZ 187617 A NZ187617 A NZ 187617A
Authority
NZ
New Zealand
Prior art keywords
pharmaceutical compositions
dihydropyridine derivatives
dihydropyridine
derivatives
pharmaceutical
Prior art date
Application number
NZ187617A
Other languages
English (en)
Inventor
P Neumann
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ187617A publication Critical patent/NZ187617A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NZ187617A 1977-06-20 1978-06-19 1,4-dihydropyridine derivatives and pharmaceutical compositions NZ187617A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH752077 1977-06-20
CH286578 1978-03-16

Publications (1)

Publication Number Publication Date
NZ187617A true NZ187617A (en) 1980-12-19

Family

ID=25691589

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ187617A NZ187617A (en) 1977-06-20 1978-06-19 1,4-dihydropyridine derivatives and pharmaceutical compositions

Country Status (20)

Country Link
EP (1) EP0000150B1 (zh)
JP (1) JPS54103876A (zh)
AT (1) AT376220B (zh)
AU (1) AU524000B2 (zh)
CA (1) CA1105463A (zh)
CY (1) CY1239A (zh)
DE (1) DE2860708D1 (zh)
DK (1) DK149855C (zh)
ES (1) ES470917A1 (zh)
FI (1) FI64938C (zh)
HK (1) HK65184A (zh)
IE (1) IE47212B1 (zh)
IL (1) IL54948A (zh)
IT (1) IT1105364B (zh)
LU (1) LU88342I2 (zh)
MY (1) MY8500041A (zh)
NL (1) NL930126I2 (zh)
NZ (1) NZ187617A (zh)
PT (1) PT68191A (zh)
SG (1) SG20584G (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
FI793848A (fi) * 1978-12-18 1980-06-19 Sandoz Ag Benzoxadiazoler och benzothiadiazoler deras framstaellning och farmaceutiska kompositioner innehaollande dessa
BE886259A (fr) * 1979-11-23 1981-05-20 Sandoz Sa Nouveaux medicament a base de derives de la 1,4-dihydropyridine, pour le traitement de l'insuffisance cerebrovasculaire ou a action spamolytique
CH655658B (zh) * 1980-09-18 1986-05-15
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner
EP0080220B1 (en) * 1981-11-17 1986-02-19 FISONS plc Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
DE3208628A1 (de) * 1982-03-10 1983-09-22 Bayer Ag, 5090 Leverkusen Neue verbindungen, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
ZA83959B (en) * 1982-03-10 1984-09-26 Sandoz Ltd 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
FR2528431B1 (fr) * 1982-06-15 1986-01-10 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation comme medicaments
FR2554109A1 (fr) * 1983-11-01 1985-05-03 Sandoz Sa Nouveaux derives de la 1,4-dihydropyridine, leur preparation et leur utilisation en therapeutique comme medicaments
IE57810B1 (en) * 1984-03-27 1993-04-21 Delagrange Lab 1,4-dihydropyridine derivatives,their preparation and their use
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8616047D0 (en) * 1986-07-01 1986-08-06 Sandoz Ltd A 1 4-dihydropyridine derivatives
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552911A (en) * 1975-07-02 1979-09-19 Fujisawa Pharmaceutical Co 1,4 dihydropyridine derivatives and the preparation thereof

Also Published As

Publication number Publication date
AT376220B (de) 1984-10-25
IE47212B1 (en) 1984-01-25
HK65184A (en) 1984-08-31
IL54948A (en) 1982-01-31
DK262578A (da) 1978-12-21
CY1239A (en) 1984-06-29
FI781867A (fi) 1978-12-21
EP0000150A1 (en) 1979-01-10
IL54948A0 (en) 1978-08-31
IT7849939A0 (it) 1978-06-19
DK149855B (da) 1986-10-13
DK149855C (da) 1987-04-21
ATA443178A (de) 1984-03-15
IE781231L (en) 1978-12-20
JPS54103876A (en) 1979-08-15
NL930126I2 (nl) 1995-02-16
EP0000150B1 (en) 1981-05-20
CA1105463A (en) 1981-07-21
AU3725278A (en) 1980-01-03
PT68191A (fr) 1978-07-01
JPS6360755B2 (zh) 1988-11-25
IT1105364B (it) 1985-10-28
NL930126I1 (nl) 1993-11-01
SG20584G (en) 1985-03-08
DE2860708D1 (en) 1981-08-27
LU88342I2 (fr) 1994-05-04
AU524000B2 (en) 1982-08-26
FI64938C (fi) 1984-02-10
FI64938B (fi) 1983-10-31
MY8500041A (en) 1985-12-31
ES470917A1 (es) 1979-10-01

Similar Documents

Publication Publication Date Title
NZ186197A (en) 3,4,5-trimethoxybenzene derivatives and pharmaceutical compositions
IL56206A0 (en) New 1,2-benzothiazine-1,1-doxide derivatives, their preparation and pharmaceutical compositions containing them
IL55465A (en) 2-alkyl-4-hydroxy-n-heteroaryl-2h-thieno(1,2)-thiazine-3-carboxamide 1,1-dioxide derivatives,their preparation and pharmaceutical compositions containing them
IL53639A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
PH16519A (en) 1,2,3,4-tetrahydro-2-amino-5-oxy-naphthalene derivatives and their pharmaceutical compositions
PH13563A (en) 2,6-diaminonebularines and compositions thereof
NZ187235A (en) Aminoalkylbenzene derivatives and pharmaceutical compositions
NZ187617A (en) 1,4-dihydropyridine derivatives and pharmaceutical compositions
NZ186189A (en) M-trifluoromethyl phenylpiderazine derivatives and pharmaceutical compositions
DE2862107D1 (en) Glucosamine-peptide derivatives and their pharmaceutical compositions
NZ188974A (en) 1,2,3,4,6,7,12,12b-octahydro(2,3-aquinolizine derivatives and pharmaceutical compositions
NZ188772A (en) Pyrazinobenzoxazepine derivatives and pharmaceutical compositions
NZ188946A (en) 1,2-benzisoxazoloxyacetic acid derivatives pharmaceutical compositions
NZ188798A (en) 2-iminoimidazolidine derivatives and pharmaceutical compositions
DE2862059D1 (en) Thiazolidinedione-2,4 derivatives, their preparation and pharmaceutical applications
NZ187085A (en) 3-pyridazione derivatives and pharmaceutical compositions
NZ187571A (en) N-glucofuranosid-6-yl-n-nitroso-urea derivatives and pharmaceutical compositions
IL54358A (en) 1-substituted-3-amino-6,7-dialkoxy-1h-1,2,4-benzothiadiazine-1-oxides,their preparation and pharmaceutical compositions containing them
NZ185539A (en) Cis-4a-aryl-2-substituted-2,3,4,4a,5,6,7,7a-octa hydro-1h-2-pyrindines and pharmaceutical compositions
NZ190092A (en) 1-benzyl-1,2,3,6-tetrahydropyridine derivatives and pharmaceutical compositions
NZ182502A (en) 1,4-dihydro-2,6-dimethyl-3-methoxycarbonyl-5-isobut-oxycarbonyl-4-(21-nitrophenyl)-pyridine and pharmaceutical compositions
NZ187825A (en) 1,2,4-oxadiazole derivatives and pharmaceutical compositions
IL53904A (en) -phenyltolyl azacycloalkane or azacycloalkene derivatives,their preparation and pharmaceutical compositions comprising them
NZ184185A (en) 3,5,5-trimethylhexanoyl-ferrocene and pharmaceutical compositions
NZ187195A (en) Benzenesulphonyl-urea derivatives and pharmaceutical compositions